 | Up a level |
Zueger, T; Schuler, V; Stettler, C; Diem, P; Christ, Er (2012). Assessment of three frequently used blood glucose monitoring devices in clinical routine. Swiss medical weekly, 142, w13631. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2012.13631
Hermanides, J; Nørgaard, K; Bruttomesso, D; Mathieu, C; Frid, A; Dayan, C M; Diem, P; Fermon, C; Wentholt, I M E; Hoekstra, J B L; Devries, J H (2011). Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type?1 diabetes; a randomized controlled trial. Diabetic medicine, 28(10), pp. 1158-67. Chichester: Wiley 10.1111/j.1464-5491.2011.03256.x
Diem, P (2011). [Diabetes/insulin - 3 contributions from 1924 and comment from the current viewpoint]. Praxis - schweizerische Rundschau für Medizin, 100(22), pp. 1339-42. Bern: Huber 10.1024/1661-8157/a000711
Trepp, R; Stettler, C; Diem, P; Christ, E R (2010). Effect of Growth Hormone (GH) on Fasting and Postprandial Metabolism in GH Deficiency. Experimental and clinical endocrinology & diabetes, 118(9), pp. 596-601. Stuttgart: Thieme 10.1055/s-0029-1243605
Spirk, D; Lareida, J; Scheidegger, K; Diem, P (2009). [Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study]. Praxis - schweizerische Rundschau für Medizin, 98(6), pp. 315-20. Bern: Huber
Scheidegger, U A; Flück, C E; Scheidegger, K; Diem, P; Mullis, P E (2009). [Role of complementary medicine in type 1 diabetes mellitus in two Swiss centres]. Praxis - schweizerische Rundschau für Medizin, 98(18), pp. 1001-5. Bern: Huber
Bethel, M A; Deedwania, P; Levitt, N S; Schmitz, O; Huntsman-Labed, A; Califf, R M; Haffner, S M; Diem, P (2009). Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population. Diabetic medicine, 26(12), pp. 1204-11. Chichester: Wiley 10.1111/j.1464-5491.2009.02864.x
Krull, I; Sahli, R; Diem, P; Stettler, C (2009). Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays. Diabetic medicine, 26(10), pp. 1075-6. Chichester: Wiley 10.1111/j.1464-5491.2009.02815.x
Liebl, A; Hoogma, R; Renard, E; Geelhoed-Duijvestijn, P H L M; Klein, E; Diglas, J; Kessler, L; Melki, V; Diem, P; Brun, J-M; Schaepelynck-Bélicar, P; Frei, T (2009). A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes, obesity and metabolism, 11(11), pp. 1001-8. Oxford: Blackwell Science 10.1111/j.1463-1326.2009.01059.x
Schnell, O; Alawi, H; Battelino, T; Ceriello, A; Diem, P; Felton, A; Grzeszczak, W; Harno, K; Kempler, P; Satman, I; Verges, B (2009). Consensus Statement on Self-Monitoring of Blood Glucose in Diabetes. Diabetes, Stoffwechsel und Herz, 2009(18(4)), pp. 285-289. Mainz: Kirchheim
Wustmann, K; Kucera, J P; Zanchi, A; Burow, A; Stuber, T; Chappuis, B; Diem, P; Delacrétaz, E (2008). Activation of electrical triggers of atrial fibrillation in hyperthyroidism. Journal of clinical endocrinology and metabolism, 93(6), pp. 2104-8. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2008-0092
Jenni, S; Oetliker, C; Allemann, S; Ith, M; Tappy, L; Wuerth, S; Egger, A; Boesch, C; Schneiter, Ph; Diem, P; Christ, E; Stettler, C (2008). Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with type 1 diabetes mellitus--a prospective single-blinded randomised crossover trial. Diabetologia, 51(8), pp. 1457-65. Heidelberg: Springer-Verlag 10.1007/s00125-008-1045-5
Stettler, C; Bearth, A; Allemann, S; Zwahlen, M; Zanchin, L; Deplazes, M; Christ, E R; Teuscher, A; Diem, P (2007). QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia, 50(1), pp. 186-94. Heidelberg: Springer-Verlag 10.1007/s00125-006-0483-1
Stettler, C; Allemann, S; Egger, M; Windecker, S; Meier, B; Diem, P (2006). Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart, 92(5), pp. 650-7. London: BMJ Publishing Group 10.1136/hrt.2005.070698
Stettler, C; Suter, Y; Allemann, S; Zwahlen, M; Christ, E R; Diem, P (2006). Apolipoprotein B as a long-term predictor of mortality in type 1 diabetes mellitus: a 15-year follow up. Journal of internal medicine, 260(3), pp. 272-80. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2796.2006.01690.x
Wille, T; Müller, B; Noth, D; Bürgi, U; Diem, P (2006). [Long-term follow up after antithyroid drug treatment in Graves' disease]. Praxis - schweizerische Rundschau für Medizin, 95(29-30), pp. 1121-7. Bern: Huber
Mueller, B; Radko, F; Diem, P (2005). Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects: response to Cavalot et al. Diabetes care, 28(11), pp. 2809-10. Alexandria, Va.: American Diabetes Association
Sahli, R; Diem, P; Christ, ER (2005). [Endogenous hypercortisolism and immunologically-mediated disease: three cases]. Deutsche medizinische Wochenschrift, 130(41), pp. 2316-8. Stuttgart: Thieme 10.1055/s-2005-918569
Solcà, C; Stanga, Z; Pandit, B; Diem, P; Greeve, J; Patel, SB (2005). Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European roots. Clinical genetics, 68(2), pp. 174-8. Oxford: Wiley-Blackwell 10.1111/j.1399-0004.2005.00472.x
Trepp, R; Stettler, C; Zwahlen, M; Seiler, R; Diem, P; Christ, ER (2005). Treatment outcomes and mortality of 94 patients with acromegaly. Acta neurochirurgica, 147(3), 243-51; discussion 250. Wien: Springer 10.1007/s00701-004-0466-2
Diem, P; Frost, SA; Augustiny, KF; Radanov, BP (2004). Quality of life and coping behaviour in Type 1 diabetes mellitus: relationship with metabolic control. Diabetes, nutrition & metabolism, 17(3), pp. 151-5. Milano: Editrice Kurtis
Diem, P; Wälchli, M; Mullis, PE; Marti, U (2004). Agreement between HbA1c measured by DCA 2000 and by HPLC: effects of fetal hemoglobin concentrations. Archives of medical research, 35(2), pp. 145-9. New York, N.Y.: Elsevier Science 10.1016/j.arcmed.2003.10.003
Diem, P; Kalt, L; Haueter, U; Krinelke, L; Fajfr, R; Reihl, B; Beyer, U (2004). Clinical performance of a continuous viscometric affinity sensor for glucose. Diabetes technology & therapeutics, 6(6), pp. 790-9. Larchmont, N.Y.: Mary Ann Liebert
Trepp, R; Müller, B; Ozdoba, Ch; Diem, P; Christ, ER (2003). [An unusual IV-expert opinion]. Praxis - schweizerische Rundschau für Medizin, 92(40), pp. 1689-92. Bern: Huber
Diem, P; Deplazes, M; Fajfr, R; Bearth, A; Müller, B; Christ, ER; Teuscher, A (2003). Effects of alcohol consumption on mortality in patients with Type 2 diabetes mellitus. Diabetologia, 46(11), pp. 1581-5. Heidelberg: Springer-Verlag 10.1007/s00125-003-1209-2
Meinhardt, U; Ammann, RA; Flück, C; Diem, P; Mullis, PE (2003). Microalbuminuria in diabetes mellitus: efficacy of a new screening method in comparison with timed overnight urine collection. Journal of diabetes and its complications, 17(5), pp. 254-7. New York, N.Y.: Elsevier 10.1016/S1056-8727(02)00180-0
Mueller, B; Stadelmann, R; Christ, E; Diem, P (2003). The 'Dead-Sea thyrotoxicosis': a side-effect of the Dead-Sea climatotherapy? European journal of dermatology EJD, 13(4), 416-7; author reply 416. Montrouge: John Libbey Eurotext
Diem, P; Laederach-Hofmann, K; Navarro, X; Mueller, B; Kennedy, WR; Robertson, RP (2003). Diagnosis of diabetic autonomic neuropathy: a multivariate approach. European journal of clinical investigation EJCI, 33(8), pp. 693-7. Oxford: Wiley-Blackwell 10.1046/j.1365-2362.2003.01195.x
Müller, B; Trepp, R; Diem, P; Christ, E (2002). [The paradox of TSH elevation in Sheehan's syndrome]. Deutsche medizinische Wochenschrift, 127(49), pp. 2610-2. Stuttgart: Thieme 10.1055/s-2002-35929
Winkler, A; Teuscher, AU; Mueller, B; Diem, P (2002). Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss medical weekly, 132(27-28), pp. 379-85. Muttenz: EMH Schweizerischer Ärzteverlag
Diem, P; Christ, E (2002). [Systematic aspects and therapy of diabetic neuropathy]. Therapeutische Umschau, 59(8), pp. 429-34. Bern: Huber
Teuscher, AU; Diem, P (2002). [Treatment of hypertension in type 2 diabetes mellitus--2002 update]. Therapeutische Umschau, 59(8), pp. 422-8. Bern: Huber
Fajfr, R; Müller, B; Diem, P (2002). [Hypophyseal incidentaloma in a patient with autosomal dominant polycystic kidney disease]. Praxis - schweizerische Rundschau für Medizin, 91(25-26), pp. 1123-6. Bern: Huber
Noth, D; Gebauer, M; Müller, B; Bürgi, U; Diem, P (2001). Graves' ophthalmopathy: natural history and treatment outcomes. Swiss medical weekly, 131(41-42), pp. 603-9. Muttenz: EMH Schweizerischer Ärzteverlag
Müller, B; Merk, S; Bürgi, U; Diem, P (2001). [Calculating the basal metabolic rate and severe and morbid obesity]. Praxis - schweizerische Rundschau für Medizin, 90(45), pp. 1955-63. Bern: Huber
Winkler, A; Mueller, B; Diem, P (2001). Masson's papillary endothelial hyperplasia mimicking a poorly differentiated thyroid carcinoma: a case report. European journal of endocrinology, 145(5), pp. 667-8. Bristol: BioScientifica Ltd. 10.1530/eje.0.1450667
Mullis, PE; O'Donovan, N; Eblé, A; Marti, U; Diem, P; Bürgi, U; Peter, HJ (2000). Growth hormone regulates growth hormone receptor gene transcription in primary human thyroid cells. Molecular and cellular endocrinology, 166(2), pp. 111-9. Shannon: Elsevier Ireland 10.1016/S0303-7207(00)00272-0
Stettler, C; Mueller, B; Diem, P (2000). [What you always wanted to know about HbA1c]. Swiss medical weekly, 130(26), pp. 993-1005. Muttenz: EMH Schweizerischer Ärzteverlag
Mueller, B; Diem, P; Bürgi, U (1998). ”Travelers' thyrotoxicosis” revisited. Archives of internal medicine, 158(15), p. 1723. Chicago, Ill.: American Medical Association 10.1001/archinte.158.15.1723
Mueller, B; Diem, P (1998). Radio emissions and Accutrend malfunction. Diabetic medicine, 15(6), pp. 524-5. Chichester: Wiley 10.1002/(SICI)1096-9136(199806)15:6<524::AID-DIA582>3.0.CO;2-U
Egger, M; Davey Smith, G; Stettler, C; Diem, P (1997). Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabetic medicine, 14(11), pp. 919-28. Chichester: Wiley 10.1002/(SICI)1096-9136(199711)14:11<919::AID-DIA456>3.0.CO;2-A
Teuscher, AU; Diem, P; Teuscher, A (1995). No increase of IDDM incidence among Swiss military conscripts. Diabetes care, 18(10), pp. 1399-40. Alexandria, Va.: American Diabetes Association
Bürgi, U; Villiger, L; Diem, P (1995). [Intensive insulin therapy--is it worth the effort?]. Therapeutische Umschau, 52(10), pp. 635-8. Bern: Huber
Diem, P (1994). [Drug therapy of type-II diabetes: tablets, insulin or a combination of these]. Praxis - schweizerische Rundschau für Medizin, 83(3), pp. 68-71. Bern: Huber
Grüssner, R; Nakhleh, R; Grüssner, A; Tomadze, G; Diem, P; Sutherland, D (1993). Streptozotocin-induced diabetes mellitus in pigs. Hormone and metabolic research, 25(4), pp. 199-203. Stuttgart: Thieme
Diem, P (1993). [Will type I diabetes mellitus be treated with immunosuppressive drugs in the future?]. Therapeutische Umschau, 50(2), pp. 114-8. Bern: Huber
Diem, P; Mullis, P; Hirt, A; Schuler, JJ; Bürgi, W; Zuppinger, KA; Teuscher, A (1993). Fetal haemoglobin levels in adult type 1 (insulin-dependent) diabetic patients. Diabetologia, 36(2), pp. 129-32. Heidelberg: Springer 10.1007/BF00400693
Egger, M; Smith, GD; Diem, P; Teuscher, A (1992). Human versus porcine insulin gone wrong. Diabetes care, 15(4), pp. 585-6. Alexandria, Va.: American Diabetes Association
Diem, P; Robertson, RP (1991). Preventive effects of octreotide (SMS 201-995) on diabetic ketogenesis during insulin withdrawal. British journal of clinical pharmacology, 32(5), pp. 563-7. Oxford: Wiley-Blackwell 10.1111/j.1365-2125.1991.tb03952.x
Diem, P; Abid, M; Redmon, JB; Sutherland, D.E.; Robertson, RP (1991). [Hyperinsulinemia as a consequence of systemic venous drainage in patients with pancreas transplantation]. Praxis - schweizerische Rundschau für Medizin, 80(43), pp. 1179-82. Bern: Huber
Robertson, RP; Diem, P; Sutherland, D.E. (1991). Time-related, cross-sectional and prospective follow-up of pancreatic endocrine function after pancreas allograft transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia, 1(34), S57-60. Heidelberg: Springer 10.1007/BF00587621
Moran, A; Diem, P; Klein, DJ; Levitt, MD; Robertson, RP (1991). Pancreatic endocrine function in cystic fibrosis. Journal of pediatrics, 118(5), pp. 715-23. New York, N.Y.: Elsevier 10.1016/S0022-3476(05)80032-0
Diem, P; Redmon, JB; Abid, M; Moran, A; Sutherland, D.E.; Halter, JB; Robertson, RP (1990). Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. Journal of clinical investigation, 86(6), pp. 2008-13. Ann Arbor, Mich.: American Society for Clinical Investigation 10.1172/JCI114936
Diem, P; Walseth, TF; Zhang, HJ; Robertson, RP (1990). Secretion and degradation of glucagon by HIT cells. Endocrinology, 127(4), pp. 1609-12. Chevy Chase, Md.: Endocrine Society 10.1210/endo-127-4-1609
Diem, P; Abid, M; Redmon, JB; Sutherland, D.E.; Robertson, RP (1990). Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes, 39(5), pp. 534-40. Alexandria, Va.: American Diabetes Association 10.2337/diabetes.39.5.534
Diem, P; Teuscher, AU; Bürgi, U (1990). Cheese turner's hypoglycaemia. Lancet, 335(8686), p. 421. London: Elsevier 10.1016/0140-6736(90)90262-4
Diem, P (1990). [Pancreas transplantation as treatment of diabetes mellitus]. Therapeutische Umschau, 47(1), pp. 87-93. Bern: Huber
Teuscher, A; Diem, P (1989). Switzerland's drug surveillance. Lancet, 2(8663), p. 621. London: Elsevier
Robertson, RP; Abid, M; Sutherland, D.E.; Diem, P (1989). Glucose homeostasis and insulin secretion in human recipients of pancreas transplantation. Diabetes, 1(38), pp. 97-8. Alexandria, Va.: American Diabetes Association
Diem, P; Zimmermann, A (1988). [Wall calcifications of the left heart atrium]. Deutsche medizinische Wochenschrift, 113(5), pp. 177-9. Stuttgart: Thieme 10.1055/s-0029-1188589
Diem, P; Spengler, H; de Weck, AL (1982). Lymphocyte transformation by insulin and insulin-zinc suspensions. Clinical and experimental immunology, 50(1), pp. 155-62. Oxford: Blackwell Scientific Publications
Teuscher, A; Diem, P (1980). Do fully synthetic and genetically synthesised human insulin differ? Lancet, 2(8205), p. 1186. London: Elsevier
